Goodness, No! Provide people with better options - and kick NNVC into gear to do the necessary work to become one of those better options.
Mapp had at least already done their animal GLP Tox Safety and Efficacy testing. Tekmira, too and they also started Phase I clinicals with people. BioCryst, Newlink and GSK are all doing the work to get to animal and Phase I safety.
I want NNVC there with EbolaCide, too. But FluCide is first to not miss that opportunity and EbolaCide needs as many resources as possible after that to put them in a position to help. Other treatments are further in development and will be used first. We need to put ourselves in a position to be a fast follower to be there should there still be a need.
But bottom line: They need to do the work and GET IT DONE!